Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jicheng Lv

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Journal of Hypertension|June 11, 2011
Blood pressure management in diabetes: a path forward?Jicheng Lv, Vlado Perkovic
Nephrology (Carlton, Vic.)|July 18, 2024
Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trialsPei Chen, Jicheng Lv
Kidney International. Supplement|March 9, 2005
Prevention of the progression of chronic kidney disease: practice in ChinaHaiyan Wang, Luxia Zhang, Jicheng Lv
JAMA|September 20, 2022
Oral Methylprednisolone and Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy-ReplyMuh Geot Wong, Jicheng Lv, Vlado Perkovic
Lancet (London, England)|June 16, 2016
Intensive blood pressure lowering - Authors' replyXinfang Xie, Emily Atkins, Jicheng Lv, et al.
Phenomics (Cham, Switzerland)|November 25, 2024
Site-Specific Quantitative N-Glycoproteomics: The Great Clinical Application Potential of GlycoQuantHao Yang, Ganglong Yang, Jicheng Lv, et al.
BMC Nephrology|January 31, 2019
Hemophagocytic lymphohistiocytosis followed by an episode of peritoneal dialysis associated peritonitis: a case reportBixia Gao, Xiaoyu Jia, Jicheng Lv, et al.
Therapeutic Advances in Chronic Disease|December 20, 2012
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trialsMin Jun, Jicheng Lv, Vlado Perkovic, et al.
BMC Nephrology|January 23, 2013
Increased plasma sVCAM-1 is associated with severity in IgA nephropathyLi Zhu, Sufang Shi, Lijun Liu, et al.
Nephrology (Carlton, Vic.)|January 16, 2016
Association between plasma phosphorus and renal outcome: A prospective cohort of patients majorly with glomerulonephritisDamin Xu, Jicheng Lv, Jinwei Wang, et al.
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Journal of Hypertension|June 11, 2011
Blood pressure management in diabetes: a path forward?Jicheng Lv, Vlado Perkovic
Nephrology (Carlton, Vic.)|July 18, 2024
Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trialsPei Chen, Jicheng Lv
Kidney International. Supplement|March 9, 2005
Prevention of the progression of chronic kidney disease: practice in ChinaHaiyan Wang, Luxia Zhang, Jicheng Lv
JAMA|September 20, 2022
Oral Methylprednisolone and Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy-ReplyMuh Geot Wong, Jicheng Lv, Vlado Perkovic
Lancet (London, England)|June 16, 2016
Intensive blood pressure lowering - Authors' replyXinfang Xie, Emily Atkins, Jicheng Lv, et al.
Phenomics (Cham, Switzerland)|November 25, 2024
Site-Specific Quantitative N-Glycoproteomics: The Great Clinical Application Potential of GlycoQuantHao Yang, Ganglong Yang, Jicheng Lv, et al.
BMC Nephrology|January 31, 2019
Hemophagocytic lymphohistiocytosis followed by an episode of peritoneal dialysis associated peritonitis: a case reportBixia Gao, Xiaoyu Jia, Jicheng Lv, et al.
Therapeutic Advances in Chronic Disease|December 20, 2012
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trialsMin Jun, Jicheng Lv, Vlado Perkovic, et al.
BMC Nephrology|January 23, 2013
Increased plasma sVCAM-1 is associated with severity in IgA nephropathyLi Zhu, Sufang Shi, Lijun Liu, et al.
Nephrology (Carlton, Vic.)|January 16, 2016
Association between plasma phosphorus and renal outcome: A prospective cohort of patients majorly with glomerulonephritisDamin Xu, Jicheng Lv, Jinwei Wang, et al.
Pageof 19